2020 has been a difficult year for everyone. However, despite the many challenges, we can also look back on some milestone achievements. In our latest newsletter, we review some of our major highlights. Click the link to read our newsletter: http://bit.ly/3njT6nQ
Would you like to receive our next newsletter in your email? You can subscribe here: https://www.tricals.org/subscribe-to-our-newsletter/
We look forward to the new year in which we will undoubtedly achieve even more together. Together we will build our highway towards new therapies for ALS.
Related news
ENCALS consensus statement on NurOwn
Background Given the interest around the use of stem cells in ALS, […]
Story behind the participant: Peter Ambühl
Many clinical trials are looking for participants. In this new interview series, […]
Apellis reports discontinuation of MERIDIAN study
Pharmaceutical company Apellis has announced the discontinuation of the open-label phase of […]
Recording of virtual meeting - Adherence and retention in ALS clinical trials
On March 22, 2023, TRICALS organised its first virtual meeting: ‘Adherence and retention […]